clinical trial · NCT05806359
A Study to Evaluate the Safety, Tolerability, and Drug Levels of Danicamtiv in Healthy Japanese and Caucasian Participants
Bristol-Myers Squibb·phase1·completed·n = 33
Healthy VolunteersDanicamtivPlacebo
brief summary
The purpose of this study is to assess the safety, tolerability, and single-dose pharmacokinetics of danicamtiv in healthy Japanese and Caucasian participants.
started
Mar 31, 2023
primary completion
Aug 14, 2023
completion
Aug 14, 2023
last updated
May 23, 2024
official title
A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Danicamtiv in Healthy Japanese and Caucasian Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol